News
The FDA has granted Fast Track Designation to Sanofi’s SAR402663, an investigational one-time intravitreal gene therapy for ...
In this episode of the Applied Clinical Trials Brief, Shipra Patel, global therapeutic area section head for endocrinology ...
In this video interview, Adrianne Rivard, senior community development manager at myTomorrows, explains why compliance with ...
Eli Lilly has shared positive results from the Phase III BRUIN CLL-313 clinical trial (NCT05023980) evaluating Jaypirca (pirtobrutinib) versus chemoimmunotherapy (bendamustine plus rituximab) in ...
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical ...
Results from a Phase II trial (NCT06449209) showed that BioNTech’s and Bristol Myers Squibb’s pumitamig in combination with ...
In this video interview, Adrianne Rivard, senior community development manager at myTomorrows, highlights how combining AI ...
Results from the Phase III ASCEND trial (NCT05882877) showed rocatinlimab maintained long-term efficacy with a favorable ...
Five-year results from the Phase III EMPOWER-Lung 3 trial show Libtayo combined with chemotherapy achieved a 19.4% overall ...
Results from the Phase III FLAUR2 trial (NCT04035486) showed that Tagrisso combined with pemetrexed and platinum-based ...
In this video interview, Adrianne Rivard, senior community development manager at myTomorrows, explains why unified, ...
Summit Therapeutics’ Bispecific Antibody Shows Positive Survival Trend in Non-Small Cell Lung Cancer
Positive Overall Survival (OS) Trend: Ivonescimab plus chemotherapy showed a favorable OS trend in EGFR-mutated NSCLC, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback